The estimated Net Worth of Michael G Atieh is at least $13.6 Milione dollars as of 3 September 2024. Mr. Atieh owns over 261 units of Chubb stock worth over $11,137,882 and over the last 10 years he sold CB stock worth over $2,030,446. In addition, he makes $423,097 as Independent Director at Chubb.
Michael has made over 10 trades of the Chubb stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 261 units of CB stock worth $75,035 on 3 September 2024.
The largest trade he's ever made was selling 2,944 units of Chubb stock on 18 August 2021 worth over $548,173. On average, Michael trades about 421 units every 82 days since 2014. As of 3 September 2024 he still owns at least 39,171 units of Chubb stock.
You can see the complete history of Mr. Atieh stock trades at the bottom of the page.
Michael G. Atieh CPA serves as Independent Director of the Company. Mr. Atieh served as Executive Vice President and Chief Financial and Business Officer of Ophthotech Corporation (a biopharmaceutical company) from September 2014 until March 2016. From February 2009 until its acquisition in February 2012, Mr. Atieh was Executive Chairman of Eyetech Inc., a private specialty pharmaceutical company. He served as Executive Vice President and Chief Financial Officer of OSI Pharmaceuticals from June 2005 until December 2008. Mr. Atieh is currently Chairman of the Board of Directors, Chairman of the Audit Committee and a member of the Nominating and Governance Committee of electroCore, Inc. He served as a member of the Board of Directors of Theravance Biopharma, Inc. from June 2014 to April 2015, and as a member of the Board of Directors and Chairman of the Audit Committee for OSI Pharmaceuticals from June 2003 to May 2005. Previously, Mr. Atieh served at Dendrite International, Inc. as Group President from January 2002 to February 2004 and as Senior Vice President and Chief Financial Officer from October 2000 to December 2001. He also served as Vice President of U.S. Human Health, a division of Merck & Co., Inc., from January 1999 to September 2000, as Senior Vice President—Merck-Medco Managed Care, L.L.C., an indirect wholly-owned subsidiary of Merck, from April 1994 to December 1998, as Vice President—Public Affairs of Merck from January 1994 to April 1994 and as Treasurer of Merck from April 1990 to December 1993.
As the Independent Director of Chubb, the total compensation of Michael Atieh at Chubb is $423,097. There are 11 executives at Chubb getting paid more, with Evan Greenberg having the highest compensation of $20,475,100.
Michael Atieh is 66, he's been the Independent Director of Chubb since 1991. There are 9 older and 18 younger executives at Chubb. The oldest executive at Chubb Limited is Eugene Shanks, 73, who is the Independent Director.
Michael's mailing address filed with the SEC is THE CHUBB BUILDING, 17 WOODBOURNE AVENUE, HAMILTON, D0, HM 08.
Over the last 9 years, insiders at Chubb have traded over $311,548,506 worth of Chubb stock and bought 26,344 units worth $3,018,506 . The most active insiders traders include Robert J Hugin, Michael P Connors e Evan G Greenberg. On average, Chubb executives and independent directors trade stock every 19 days with the average trade being worth of $5,973,699. The most recent stock trade was executed by Evan G Greenberg on 6 September 2024, trading 60,855 units of CB stock currently worth $17,551,799.
Chubb Limited is an American company incorporated in Zürich, Switzerland. It is the parent company of Chubb, a global provider of insurance products covering property and casualty, accident and health, reinsurance, and life insurance and the largest publicly traded property and casualty company in the world.
Chubb executives and other stock owners filed with the SEC include: